Your browser doesn't support javascript.
loading
Evaluation of the safety and efficacy of humanized anti-CD19 chimeric antigen receptor T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma based on the comprehensive geriatric assessment system.
Zhang, Huan; Liu, Man; Li, Qing; Lyu, Cuicui; Jiang, Yan-Yu; Meng, Juan-Xia; Li, Jing-Yi; Deng, Qi.
Afiliação
  • Zhang H; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Liu M; Department of Surgery Plastic, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Li Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Lyu C; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Jiang YY; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Meng JX; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Li JY; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
  • Deng Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Leuk Lymphoma ; 63(2): 353-361, 2022 02.
Article em En | MEDLINE | ID: mdl-34587859

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Limite: Aged / Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Receptores de Antígenos Quiméricos Limite: Aged / Humans Idioma: En Revista: Leuk Lymphoma Ano de publicação: 2022 Tipo de documento: Article